The present invention relates to compounds of formula (I)
that useful in treating pain.
本发明涉及一种用于治疗疼痛的化合物,其化学式为(I)。
[EN] COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET<br/>[FR] COMPOSÉS UTILES POUR TRAITER DES TROUBLES LIÉS À RET
申请人:BLUEPRINT MEDICINES CORP
公开号:WO2018017983A1
公开(公告)日:2018-01-25
Described herein are compounds of formula (I) that inhibit wild- type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
The present invention relates to compounds of formula (I-VII)
or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of trating pain using these compounds and pharmaceutical compositions including these compounds.
The present invention relates to compounds of formula (I-VII)
or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R
6
, R
7
and R
8
are defined herein. The present invention also relates to methods of treating pain using these compounds and pharmaceutical compositions including these compounds.
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
申请人:Merck Sharp & Dohme Corp.
公开号:US20150218169A1
公开(公告)日:2015-08-06
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.